TABLE 2.
Clinical form | TNF-α production
|
IL-10 production
|
||||||
---|---|---|---|---|---|---|---|---|
No. of TNF-α+ cellsa
|
% Contribution of CD68+ cellsb | % Commitment of CD68+ cellsc | No. of IL-10+ cellsa
|
% Contribution of CD68+ cellsb | % Commitment of CD68+ cellsc | |||
Total | CD68+ | Total | CD68+ | |||||
CL (n = 14) | 1,144 ± 691 | 909 ± 547 | 78 ± 12 | 65 ± 21 | 2,025 ± 785 | 1,267 ± 598 | 62 ± 13 | 79 ± 16 |
ML (n = 7) | 1,354 ± 993 | 1,148 ± 937 | 80 ± 12 | 56 ± 23 | 2,468 ± 1,597 | 1,148 ± 1,158 | 53 ± 17 | 91 ± 4d |
Counted based on expression of specific fluorescent markers for TNF-α or IL-10 either alone or together with CD68, as described in Materials and Methods.
Calculated as the percentage of CD68+ cells expressing the cytokine in relation to the total expression of the cytokine.
Calculated as the percentage of CD68+ cells expressing the cytokine in relation to total CD68+ cells.
Statistically significantly different from the value for CL (P < 0.05).